// App-Quantinova.ai

THU0391 : ANTI-TNF THERAPY IN SEVERE AND REFRACTORY SARCOIDOSIS: MULTICENTER STUDY OF 25 PATIENTS

Researchers

Presenter

  • I. Perez-Martin

Principal Investigators

  • R. Blanco

  • N. Ortego

  • H. Fernandez-Llaca

  • A. Oterino

  • M.J. Sedano

  • M. Agudo

  • A. Corrales

  • V.M. Martinez-Taboada

  • M.A. Gonzalez-Gay

  • V. Llorens-Belles

  • A. Adan

  • A. Olive

  • W.A. Sifuentes Giraldo

  • S. Gonzalez

  • C. Bejerano

  • M.C. Gonzalez-Vela

  • M.A. Gonzalez-Lopez

Medical Centers

  • Cabuenes Hospital, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Septic shock

  • Sarcoidosis

  • Inflammatory Arthritis

  • Cap myopathy

  • Aortic wall inflammation

  • Uveitis

  • Chilblains

  • Shingles

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Methylprednisolone

  • sulphasalazine

  • Oraprine

  • Cyclosporine eent

  • Methotrexate

  • Adalimumab

  • Infliximab

  • Etanercept

  • CHS-0214

  • Prednisone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved